Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study

INTRODUCTION: The INPULSIS-ON trial demonstrated that nintedanib reduced decline in forced vital capacity (FVC) and low pulmonary function (%FVC < 50%) of patients with idiopathic pulmonary fibrosis (IPF). However, there is no sufficient evidence in real world. OBJECTIVES: Reveal the utility and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Abe, Mitsuhiro, Tsushima, Kenji, Sakayori, Masashi, Suzuki, Kenichi, Ikari, Jun, Terada, Jiro, Tatsumi, Koichiro
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6186773/
https://ncbi.nlm.nih.gov/pubmed/30349191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S179427
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados